Blocking known cancer driver unexpectedly reveals a new tumor-promoting pathway

Posted by on May 17, 2016 5:08 pm
Categories: health

While investigating a potential therapeutic target for the ERK1 and 2 pathway, a widely expressed signaling molecule known to drive cancer growth in one third of patients with colorectal cancer, researchers found that an alternative pathway immediately emerges when ERK1/2 is halted, thus allowing tumor cell proliferation to continue.

Leave a Reply

Your email address will not be published. Required fields are marked *